Skip to Main Content

Paper Details

The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.
Int Immunopharmacol
1
2023
Author NameAffiliation
Zhengping ZhuangNational Cancer Institute, National Institutes of Health
Karel PacakEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2